Skip to main content

Advertisement

SpringerLink
Log in

Antithrombin III (ATILL) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study

  • Original
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Background: ATIII is decreased in sepsis and/or shock and its baseline value correlates with mortality. The efficacy of ATIII therapy on mortality was assessed in a selected group of patients admitted to the intensive care unit (ICU) in a double-blind, randomized, multicenter study.

Methods: 120 patients admitted to the ICU with an ATIII concentration < 70% were randomized to receive ATIII (total dose 24000 units) or placebo treatment for 5 days; 56 patients had septic shock.

Results: ATIII concentrations in the treated group remained constant throughout the treatment period (range 97–102%). The Kaplan-Meier analysis showed no difference in overall survival between the two groups: 50 and 46 % for ATIII and placebo, respectively. Septic shock and hemodynamic support were unbalanced in the two groups at admission. Therefore the Cox analysis was carried out after adjusting for these two variables. Treatment with ATIII decreases the risk of death with an odds ratio (OR) of 0.56. Of the covariates analyzed, septic shock and the baseline multiple organ failure score were negatively associated with survival and plasma activity level was positively associated with survival with an OR of 0.97 for each 1 % increase in the ATIII plasma concentration at baseline.

Conclusions: The results of ATIII treatment in this population of patients suggests that replacement therapy reduces mortality in the subgroup of septic shock patients only.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Buller HR, Ten Cate JW (1989) Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications and treatment with antithrombin III concentrate. Am J Med 87 [Suppl 3B]: 44s-48s

    Article  PubMed  CAS  Google Scholar 

  2. Blauhut B, Necek S, Vinazzer H, Bergmann H (1982) Substitution therapy with an antithrombin III concentrate in shock and DIC. Thromb Res 27: 271–278

    Article  PubMed  CAS  Google Scholar 

  3. Hesselvik JF, Malm J, Dahlback B, Blomback M (1991) Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Hemost 62: 126–129

    Google Scholar 

  4. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, Marey A, Lestavel P (1992) Septic shock, multi organ failure and disseminated intravascular coagulation. Compared pattern of ATIII, protein C, protein S deficiencies. Chest 101: 816–823

    Article  PubMed  CAS  Google Scholar 

  5. Blauhut B, Kramar H, Vinazzer H, Bergmann H (1984) Substitution of antithrombin III in shock and DIC: a randomized study. Thromb Res 39: 81–89

    Article  Google Scholar 

  6. Wilson RF, Mammen EF, Robson MC, Heggers JP, Soullier G, DePoli PA (1986) Antithrombin, prekallikrein and fibronectin levels in surgical patients. Arch Surg 121: 635–643

    PubMed  CAS  Google Scholar 

  7. Sandset PM, Roise O, Aasen AO, Abildgaard U (1989) Extrinsic pathway inhibitor in post operative post traumatic septicaemia: increased levels in fatal cases. Hemostasis 19: 189–195

    CAS  Google Scholar 

  8. Hesselvik JF, Blomback M, Brodin B, Maller R (1989) Coagulation, fibrinolysis and kallikrein systems in sepsis: relation to outcome. Crit Care Med 17: 724–733

    PubMed  CAS  Google Scholar 

  9. Lammle B, Tran TM, Ritz R, Duckert F (1984) Plasma prekallikrein, factor XII, ATIII, C1-inhibitor and α2 macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol 82: 396–404

    PubMed  CAS  Google Scholar 

  10. Maki M, Terao T, Ikenoue T, Takemura T, Sekiba K, Shirakawa K, Soma H (1987) Clinical evaluation of antithrombin concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Gynecol Obstet Invest 23: 230–240

    PubMed  CAS  Google Scholar 

  11. Vinazzer H (1989) Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation. Semin Thromb Hemost 15: 347–352

    Article  PubMed  CAS  Google Scholar 

  12. Fourrier F, Chopin C, Huart JJ, Runge I, Caron C, Goudemand J (1993) Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104: 882–888

    Article  PubMed  CAS  Google Scholar 

  13. Lamy M, Eisele B, Keinecke H-O, Delvos U, Thijs LG (1996) Antithrombin III in patients with severe sepsis. A randomised, placebo-controlled, double-blind multicenter trial. Abstr.9th European Congress on Intensive Care Medicine, pp 385–390, Glasgow

  14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13: 818–829

    Article  PubMed  CAS  Google Scholar 

  15. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis (1992). Crit Care Med 20: 864–874

    Article  Google Scholar 

  16. La Gall JR, Loirat P, Alperovith A, Glaser P, Granthil C, Mathieu D, Mercier P, Thomas R, Villers D (1984) A simplified acute physiology score for ICU patients. Crit Care Med 12: 975–977

    Article  PubMed  Google Scholar 

  17. Goris RJA, Boekhorst TP, Nuytinck JKS, Gimbrere JSF (1985) Multiple organ failure. Arch Surg 120: 1109–1115

    PubMed  CAS  Google Scholar 

  18. Lechner K, Kyrie PA (1995) Antithrombin III concentrates — are they clinically useful? Thromb Haemost 73: 340–348

    PubMed  CAS  Google Scholar 

  19. Salvo I, DeCian W, Musicco M, Langer M, Piadena R, Wolfler A, Mowtani C, Magni E (1995) The Italian SEPSIS study: preliminary results on incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 21: S244-S249

    Article  PubMed  Google Scholar 

  20. Dickneite G, Paques EP (1993) Reduction of mortality with antithrombin III in septicaemia rats: a study of Klebsiella pneumoniae induced sepsis. Thromb Haemost 69: 98–102

    PubMed  CAS  Google Scholar 

  21. Kessler CM, Tang ZC, Jacobs HM, Szymanski LM (1997) The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity. Blood 89: 4393–4401

    PubMed  CAS  Google Scholar 

  22. Jochum M (1995) Influence of high-dose antithrombin concentrate therapy on the release of cellular proteinases, cytokines and soluble adhesion molecules in acute inflammation Semin Hematol 32: 19–32

    PubMed  CAS  Google Scholar 

  23. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J (1996) Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 88: 881–886

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Hemostasis and Thrombosis Unit, Ospedale Niguarda, Milano, Italy

    F. Baudo, T. M. Caimi & F. deCataldo

  2. Department of Intensive Care, Ospedale Niguarda, Milano, Italy

    A. Ravizza, S. Arlati, G. Casella & D. Carugo

  3. Department of Angiology, Ospedale S. Orsola, Bologna, Italy

    G. Palareti & C. Legnani

  4. Department of Intensive Care, Ospedale S. Orsola, Bologna, Italy

    L. Ridolfi & R. Rossi

  5. Hemostasis Laboratory, Ospedale S. Raffaele, Milano, Italy

    A. D’Angelo & L. Crippa

  6. Intensive Care Unit, Ospedale S. Raffaele, Milano, Italy

    D. Giudici, G. Gallioli & A. Wolfler

  7. Epidemiology Unit, Ospedale S. Raffaele, Milano, Italy

    G. Calori

Authors
  1. F. Baudo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. M. Caimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. deCataldo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Ravizza
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Arlati
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Casella
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Carugo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Palareti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C. Legnani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. L. Ridolfi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R. Rossi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A. D’Angelo
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. L. Crippa
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. D. Giudici
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. G. Gallioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. A. Wolfler
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. G. Calori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Baudo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baudo, F., Caimi, T.M., deCataldo, F. et al. Antithrombin III (ATILL) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med 24, 336–342 (1998). https://doi.org/10.1007/s001340050576

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001340050576

Keywords

Search

Navigation